Table 2 Expression of LAG-3, PD-1, and PD-L1, CD3, GZMB in NSCLC patients
Characteristics | Cases (n = 182) | Percentage (%) |
|---|---|---|
LAG-3 expression on TILs | ||
 High | 147 | 80.8 |
 Low | 35 | 19.2 |
PD-1 expression on TILs | ||
 High | 90 | 49.5 |
 Low | 92 | 50.5 |
PD-L1 expression on TC | ||
 High | 39 | 21.4 |
 Low | 143 | 78.6 |
PD-L1 expression on TILs | ||
 High | 154 | 84.6 |
 Low | 28 | 15.4 |
CD3+ TIL | ||
 High | 125 | 68.7 |
 Low | 57 | 31.3 |
GZMB | ||
 High | 44 | 24.2 |
 Low | 138 | 75.8 |